Glenmark Pharma Soars 10% To Record High After AbbVie Cancer Drug Deal; Details
Shares of Glenmark Pharmaceuticals Ltd surged 10 per cent in early trade on Friday; Key points for investors
Glenmark Share Price: Shares of Glenmark Pharmaceuticals Ltd surged 10 per cent in early trade on Friday, scaling a new all-time high of Rs 2,094 apiece, after the company announced a major licensing agreement involving its innovation subsidiary.
In a regulatory filing post market hours on July 10, Glenmark said its step-down wholly-owned subsidiary, Ichnos Glenmark Innovation (IGI), had signed a global licensing pact with AbbVie. The investigational drug, ISB 2001, is currently undergoing Phase 1 clinical trials for patients with relapsed or refractory multiple myeloma, a form of blood cancer.
Under the terms of the agreement, AbbVie will obtain exclusive rights to develop, manufacture, and commercialize ISB 2001 across key developed markets, including North America, Europe, Japan, and China. Glenmark will retain commercialization rights across emerging markets such as the rest of Asia, Latin America, Russia/CIS, the Middle East, Africa, Australia, New Zealand, and South Korea.
Glenmark's IGI Therapeutics SA will receive an upfront payment of $700 million and may earn up to $1.225 billion in additional milestone payments tied to development, regulatory clearances, and commercial success. The deal also includes tiered, double-digit royalties on net sales.
The US FDA granted ISB 2001 orphan drug designation in July 2023 and fast-track designation in May 2025 for treating relapsed or refractory multiple myeloma. These designations are expected to speed up the drug's development and approval process.
Roopal Thakkar, M.D., EVP of R&D and Chief Scientific Officer at AbbVie, said, 'Multispecifics, including trispecific antibodies, are a new frontier in immuno-oncology. This partnership underscores our commitment to advancing novel treatments for multiple myeloma, where unmet medical needs still exist."
Cyril Konto, M.D., President and CEO of IGI, added, 'ISB 2001 showcases the power of our BEAT® protein platform to create next-generation multispecifics™. This agreement is a defining moment in IGI's journey and accelerates the drug's path to patients."
Stock Performance and Analyst Take
Glenmark Pharma shares have surged over 14% in the past five sessions, 28% in one month, and more than 51% over the past year. Despite the rally, Nomura has maintained a 'Neutral' rating on the stock with a price target of Rs 1,500, implying over 21% downside from its previous close of Rs 1,904. The brokerage noted that the deal is the largest licensing agreement signed by an Indian pharmaceutical firm and exceeded its expectations in value.
view comments
First Published:
July 11, 2025, 10:41 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
43 minutes ago
- Time of India
Uran Girl Finds a Place in Team India for International Shooting Show
Navi Mumbai: A talented young shooter from Uran secured a position in India's national shooting contingent for an international competition. Shooting sport encompasses the use of various firearms, including guns, pistols, and airguns, testing accuracy, speed, and targeting skills. The sport features multiple categories such as rifle, air pistol, rifle 50 metres, shotgun, trap, double trap, and skeet, where competitors target from varying distances. Avani Koli (19), hailing from Dighode village in Uran taluka, qualified for the Indian shooting team for her first international competition. Coming from a humble background, Avani demonstrated excellence in double trap shotgun events across district, division, state, and national levels. Her parents challenged rural conventions regarding girls' traditional roles by backing her sporting aspirations. Her development was guided by her father, Alankar Koli, who serves as a national shooter-cum-coach and former deputy sarpanch. Despite equipment constraints, she accumulated numerous medals in shotgun shooting. Her family, including mother Kavita, who manages home affairs, and brother Arnav, an inter-school competition achiever, provides unwavering support. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Đây có thể là thời điểm tốt nhất để giao dịch vàng trong 5 năm qua IC Markets Tìm hiểu thêm Undo She studied at Indian Model School and Junior College, Ulwe, and currently pursues BSc first year at Veer Wajekar College, Funde, Uran. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai Her shooting journey began at age 12 at Siddhant Rifle and Pistol Shooting Club, Raigad, under Kishan Kharke and Commonwealth Games medallist Sheela Kanungo. As Uran's pioneering shooter, she competed successfully at various levels, showing resilience through injuries. "I worked very hard to achieve this position. Donning the tri-colour on the international stage will certainly boost my morale to perform even better," said Avani. "In 2023, under Ralston Coylo's guidance at Chhatrapati Stadium, Balewadi, Pune, she excelled in double trap shooting. In 2024-25, she secured two national gold medals representing Maharashtra," said her father. Her selection for the Asian Shooting Championship 2025 in Kazakhstan from August 14 to August 28, 2025, establishes her as Raigad and Navi Mumbai's first representative in the Double Trap Shotgun Junior Women's category, earning widespread acclaim.
Time of India
43 minutes ago
- Time of India
Auric will get 10,000 acres for expansion, says secretary of department for promotion of industry & internal trade
Chhatrapati Sambhajinagar: Amardeep Singh Bhatia, the secretary of Centre's department for promotion of industry and internal trade (DPIIT) at the Centre, announced on Saturday that the Aurangabad Industrial City (Auric) will undergo further expansion on 10,000 acres of land. "Auric will play a key role in the path to achieving a $30 trillion economy for India by 2047. It has been playing a pioneering role by emerging as a vibrant manufacturing hub," Bhatia said during his visit to Auric at Chhatrapati Sambhajinagar. Auric is a greenfield industrial smart city taking shape over 10,000 acres as part of the Delhi-Mumbai Industrial Corridor (DMIC). The industrial city is being developed in Bidkin and Shendra nodes, with the Bidkin node already attracting significant investments from electric vehicle manufacturers, among others. Bhatia added that Centre plans to establish 100 additional industrial cities like Auric across the country. "In order to achieve the $30 trillion economy target, we have to grow at the rate of 9 to 10% every year. The development of manufacturing hubs is crucial to achieve this," he said. P Anbalagan, the principal secretary of the state industries department, who accompanied the Union secretary, said, "The necessary notification would be issued in the next two to three months, paving the way for the expansion of the AURIC." Bhatia also visited the Marathwada Accelerator for Growth and Incubation Council (MAGIC), emphasising that Indian startups should focus on building world-class products. "The Indian startups need to focus not just on India but on global markets. The country has emerged as the third-largest startup ecosystem globally," he said, praising MAGIC for securing more than 20 patents for startups and supporting tier-2 and tier-3 cities. Speaking on the occasion, Anbalagan announced that 15 new policies would soon be introduced by state govt, covering sectors such as defence, event management, logistics, deep technology, and special MSME support. "Funding worth Rs 3,000 crore will be made available across various domains for startups. Additionally, the 'MAITRI 2.0' portal will soon be launched, offering approvals for over 120 services through a single-window system," he said.
Time of India
43 minutes ago
- Time of India
Family of brain-dead youth donates organs, saves 3 lives
1 2 Chandigarh: The PGI witnessed another inspiring moment as the family of a young engineering student turned personal tragedy into hope for others by donating his vital organs. Navneet Singh, 23, a resident of Gangath village, Nurpur, Kangra, suffered a severe head injury after accidentally falling from a rooftop on July 3. Despite receiving intensive medical care at PGI, he was declared brain dead on July 11. Amidst their grief, Navneet's father, Janak Singh, made the courageous decision to donate his son's organs. "Deciding to donate my son's organs was the hardest choice we have ever faced. But knowing that his organs would give others a chance to live has brought us some comfort in our sorrow. We are proud that Navneet's legacy will continue through these lives," he said. Following the family's consent, PGI's transplant teams retrieved Navneet's heart, kidneys, and pancreas. The kidneys and pancreas were transplanted into two critically ill patients at PGI, while the heart was allocated to a matching recipient at RML Hospital, New Delhi, through the National Organ and Tissue Transplant Organization (NOTTO), as no suitable recipient was available at PGI. To ensure timely transport of the donor heart, a dedicated green corridor was created from PGI to Chandigarh International Airport, Mohali, and onward to New Delhi. The heart was successfully transplanted into a 26-year-old patient admitted at RML Hospital. At PGI, the department of renal transplant surgery, led by Prof Ashish Sharma, performed a simultaneous kidney-pancreas transplant on one recipient. This marked PGI's 63rd pancreas transplant — the highest number of such procedures performed by any institution across Indian states and union territories — curing the patient of Type I diabetes. The second kidney was transplanted into another patient suffering from end-stage renal failure and undergoing long-term dialysis.
